Search hospitals > Illinois > Normal

Community Cancer Center

Claim this profile
Normal, Illinois 61761
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Lymphoma
Conducts research for Cancer
Conducts research for Leukemia
225 reported clinical trials
8 medical researchers
Photo of Community Cancer Center in NormalPhoto of Community Cancer Center in NormalPhoto of Community Cancer Center in Normal

Summary

Community Cancer Center is a medical facility located in Normal, Illinois. This center is recognized for care of Breast Cancer, Lung Cancer, Lymphoma, Cancer, Leukemia and other specialties. Community Cancer Center is involved with conducting 225 clinical trials across 260 conditions. There are 8 research doctors associated with this hospital, such as Suparna Mantha, Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, and Pratima Chalasani.

Area of expertise

1Breast Cancer
Global Leader
Community Cancer Center has run 60 trials for Breast Cancer. Some of their research focus areas include:
ER positive
PR positive
HER2 negative
2Lung Cancer
Global Leader
Community Cancer Center has run 32 trials for Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
Stage III

Top PIs

Clinical Trials running at Community Cancer Center

Breast Cancer
Cancer
Ovarian Cancer
Breast cancer
Uterine Cancer
Colorectal Cancer
Lymphoma
Esophageal cancer
Melanoma
Pancreatic Cancer
Image of trial facility.

Mindfulness Approaches

for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.
Recruiting2 awards Phase 35 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Community Cancer Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security